Evaluation of the effect of food on the pharmacokinetics of avitriptan

被引:0
作者
Marathe, PH
Greene, DS
Kollia, GD
Barbhaiya, RH
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Biostat & Data Management, Princeton, NJ 08543 USA
关键词
avitriptan; food effect; bioavailability;
D O I
10.1002/(SICI)1099-081X(199809)19:6<381::AID-BDD118>3.3.CO;2-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bioavailability of avitriptan was found to decrease significantly when administered 5 min after a standard high fat meal. The studies described herein were carried out to gain insight into the mechanism of this food effect. A series of studies were conducted in humans to assess the effect of timing of meal, type of meal, gastric pH, change in the formulation and dose on the bioavailability of avitriptan. Avitriptan was administered as a 50 mg capsule under fasted condition and at 30 min, 1, 2 and 4 h after a standard high fat meal. The reduction in avitriptan bioavailability persisted even at 4 h post high fat meal, although as the time interval between the meal and dose increased, the effect of meal tended to decrease. Bioavailability of avitriptan also decreased significantly when the drug was administered after a high protein and a high carbohydrate meal. Elevation in gastric pH caused by food was not found to be responsible for the food-related decrease in bioavailability of avitriptan since ranitidine pretreatment did not lead to a decrease in bioavailability. When administered as a 50 mg C-14-labeled solution after a standard high fat meal, bioavailability of avitriptan decreased although the decrease was less compared with that observed for a capsule dosage form. Plasma concentrations and cumulative urinary excretion of total radioactivity also decreased in the fed condition, indicating the absorption of avitriptan was affected. The decrease in avitriptan AUC was somewhat more pronounced than the decrease in the exposure to the total radioactivity suggesting a food-related increase in the first-pass metabolism of avitriptan. Effect of the standard high fat meal on avitriptan administered as a 150 mg capsule was similar to that observed at the 50 mg dose. Overall, the results indicate that bioavailability of avitriptan is significantly reduced irrespective of the type of meal, dose and dosage form and the effect persists for as long as 4 h post meal. Thus, it appears that avitriptan absorption and bioavailability are highly sensitive to presence of food in the stomach and any food-related changes in gastric emptying time and gastrointestinal motility. (C) 1998 John Wiley & Sons, Ltd.
引用
收藏
页码:381 / 394
页数:14
相关论文
共 50 条
  • [41] Absence of food effect on the pharmacokinetics of telbivudine following oral administration in healthy subjects
    Zhou, XJ
    Lloyd, DM
    Chao, GC
    Brown, NA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (03) : 275 - 281
  • [42] Target site pharmacokinetics of doxycycline for rosacea in healthy volunteers is independent of the food effect
    Pal, Arindam
    Matzneller, Peter
    Gautam, Anirudh
    Oesterreicher, Zoe
    Wulkersdorfer, Beatrix
    Reiter, Birgit
    Stimpfl, Thomas
    Zeitlinger, Markus
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (11) : 2625 - 2633
  • [43] Pharmacokinetics, Safety, and Bioequivalence of 2 Lopinavir/Ritonavir (200/50 mg) Tablets in Healthy Chinese Volunteers: Effect of Food on Absorption
    Zhang, Wei
    Lin, Lili
    Fu, Wanjin
    Bao, Dandan
    Zhang, Qian
    Liu, Yueyue
    Zheng, Liang
    Hu, Wei
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (06): : 602 - 610
  • [44] The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast
    Schug, BS
    Brendel, E
    Chantraine, E
    Wolf, D
    Martin, W
    Schall, R
    Blume, HH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (06) : 582 - 588
  • [45] Effect of Food on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, and Assessment of Dose Proportionality in Healthy Participants
    Devineni, Damayanthi
    Manitpisitkul, Prasarn
    Murphy, Joseph
    Stieltjes, Hans
    Ariyawansa, Jay
    Di Prospero, Nicholas A.
    Rothenberg, Paul
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (04): : 279 - 286
  • [46] Effect of food on the pharmacokinetics of erlotinib, an orally active epidermal growth factor receptor tyrosine-kinase inhibitor, in healthy individuals
    Ling, Jie
    Fettner, Scott
    Lum, Bert L.
    Riek, Myriam
    Rakhit, Ashok
    ANTI-CANCER DRUGS, 2008, 19 (02) : 209 - 216
  • [47] Formulation optimization and pharmacokinetics evaluation of oral self-microemulsifying drug delivery system for poorly water soluble drug cinacalcet and no food effect
    Cao, Mengyuan
    Xue, Xu
    Pei, Xixi
    Qian, Yiwen
    Liu, Lan
    Ren, Lili
    Chen, Guoguang
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2018, 44 (06) : 969 - 981
  • [48] Evaluation of D-Ribose Pharmacokinetics, Dose Proportionality, Food Effect, and Pharmacodynamics after Oral Solution Administration in Healthy Male and Female Subjects
    Thompson, Jeff
    Neutel, Joel
    Homer, Ken
    Tempero, Ken
    Shah, Ajit
    Khankari, Raj
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05) : 546 - 554
  • [49] Pharmacokinetics of Rabeprazole Granules Versus Tablets, and the Effect of Food on the Pharmacokinetics of Rabeprazole Granules in Healthy Adults-Cross-Study Comparison
    Thyssen, An
    Solanki, Bhavna
    Gonzalez, Martha
    Leitz, Gerhard
    Treem, William
    Mannaert, Erik
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (05): : 406 - 416
  • [50] The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia
    Jan de Jong
    Juthamas Sukbuntherng
    Donna Skee
    Joe Murphy
    Susan O’Brien
    John C. Byrd
    Danelle James
    Peter Hellemans
    David J. Loury
    Juhui Jiao
    Vijay Chauhan
    Erik Mannaert
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 907 - 916